Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication.

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 15, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions

Any Solid Oral Medication

Interventions

DEVICE

Use of ReX to dispense and monitor solid oral medication therapy.

ReX Remote Digital Nurse comprising hand-held dispenser, disposable drug cartridge and web application (ReX Treatment Manager).

Trial Locations (1)

RECRUITING

OHC, Cincinnati

All Listed Sponsors

collaborator

US Oncology Research

INDUSTRY

lead

Dosentrx Ltd.

INDUSTRY

NCT06335758 - Non-randomized Observational Study to Evaluate ReX® in the Management of Solid Oral Medication. | Biotech Hunter | Biotech Hunter